Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Single-arm, multicentre, phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER study
Yuki Katsuya, Hidehito Horinouchi, Takashi Seto, Shigeki Umemura, Yukio Hosomi, Miyako Satouchi and 7 more
- Rank
- 31 of 538
- Percentile
- top 5.8%
- Where
- European Journal of Cancer, 2019
- Citations
- 146
From the 2019 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.